US2018327441A1PendingUtilityA1

Uracyl spirooxetane nucleosides

68
Assignee: JANSSEN SCIENCES IRELAND UCPriority: May 25, 2012Filed: Jul 24, 2018Published: Nov 15, 2018
Est. expiryMay 25, 2032(~5.8 yrs left)· nominal 20-yr term from priority
Inventors:Ioannis Nicolaos HoupisTim Hugo Maria JonckersPierre Jean-Marie Bernard RaboissonAbdellah Tahri
A61P 43/00A61P 31/14A61K 31/7072C07H 1/00C07H 19/11C07H 19/06C07H 19/10C07H 19/24
68
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present invention also relates to processes for preparing said compounds, pharmaceutical compositions containing them and their use, alone or in combination with other HCV inhibitors, in HCV therapy.

Claims

exact text as granted — not AI-modified
1 - 13 . (canceled) 
     
     
         14 . A compound of formula

Join the waitlist — get patent alerts

Track US2018327441A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.